DrugPatentWatch Database Preview

Empagliflozin - Generic Drug Details

« Back to Dashboard

What are the generic sources for empagliflozin and what is the scope of empagliflozin patent protection?

Empagliflozin is the generic ingredient in four branded drugs marketed by Boehringer Ingelheim and is included in four NDAs. There are fifteen patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Empagliflozin has one hundred and ninety patent family members in forty-three countries.

There are twenty-two drug master file entries for empagliflozin. Four suppliers are listed for this compound.

Summary for empagliflozin

International Patents:	190
US Patents:	15
Tradenames:	4
Applicants:	1
NDAs:	4
Drug Master File Entries:	22
Suppliers / Packagers:	4
Bulk Api Vendors:	64
Clinical Trials:	144
Patent Applications:	131
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for empagliflozin
DailyMed Link:	empagliflozin at DailyMed

Pharmacology for empagliflozin

Drug Class	Sodium-Glucose Cotransporter 2 Inhibitor
Mechanism of Action	Sodium-Glucose Transporter 2 Inhibitors

Synonyms for empagliflozin

(1S)-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucitol

(1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol

(1S)-1,5-anhydro-1-C-{4-chloro-3-((4-{((3S)-oxolan-3-yl)oxy}phenyl)methyl)phenyl}-D-glucitol

(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol

(2S,3R,4R,5S,6R)-2-[4-chloro-3-({4-[(3S)-oxolan-3-yloxy]phenyl}methyl)phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol

(2S,3R,4R,5S,6R)-2-[4-CHLORO-3-[[4-[(3S)-OXOLAN-3-YL]OXYPHENYL]METHYL]PHENYL]-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL

(2S,3R,4R,5S,6R)-2-[4-Chloro-3-[[4-[(3S)-tetrahydrofuran-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol

(S)-Empagliflozin D4

1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene

1314556-33-6

4CH-023469

864070-44-0

AC-27643

AJ-93046

AK160980

AKOS024464680

AX8293990

BBL104150

BC600492

BDBM150162

BI 10773

BI-10773

BI-10773;Empagliflozin

BI10773

C23H27ClO7

CE0108

CHEBI:82720

CHEMBL2107830

CS-0940

D10459

DB09038

DS-9824

Empagliflozin (BI-10773;BI 10773;BI10773)

Empagliflozin (BI 10773)

Empagliflozin (BI10773)

Empagliflozin (JAN/USAN/INN)

Empagliflozin [USAN:INN]

EX-A414

GTPL4754

HDC1R2M35U

HY-15409

JARDIANCE

Jardiance (TN)

KB-76792

KS-0000072W

MolPort-027-720-828

PB23119

Q-4526

s8022

SC-15843

SCHEMBL899986

ST24046679

STL557964

SW219120-1

Tube106

UNII-HDC1R2M35U

US8980829, EMPAGLIFLOZIN

VA10802

X5927

ZINC36520252

US Patents and Regulatory Information for empagliflozin

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Boehringer Ingelheim	GLYXAMBI	empagliflozin; linagliptin	TABLET;ORAL	206073-002	Jan 30, 2015		RX	Yes	Yes			Y
Boehringer Ingelheim	GLYXAMBI	empagliflozin; linagliptin	TABLET;ORAL	206073-001	Jan 30, 2015		RX	Yes	No
Boehringer Ingelheim	GLYXAMBI	empagliflozin; linagliptin	TABLET;ORAL	206073-001	Jan 30, 2015		RX	Yes	No			Y
Boehringer Ingelheim	SYNJARDY	empagliflozin; metformin hydrochloride	TABLET;ORAL	206111-003	Aug 26, 2015		RX	Yes	No			Y	Y

International Patents for empagliflozin

Country	Patent Number	Estimated Expiration
Hong Kong	1188777
Chile	2015002941
World Intellectual Property Organization (WIPO)	2014161918
Cyprus	1112948

Supplementary Protection Certificates for empagliflozin

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2187879	1790019-2	Sweden		PRODUCT NAME: COMBINATION OF EMPAGLIFLOZIN AND LINAGLIPTIN OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REG. NO/DATE: EU/1/16/1146 20161115
1730131	C01730131/01	Switzerland		PRODUCT NAME: EMPAGLIFLOZIN; REGISTRATION NO/DATE: SWISSMEDIC 63227 12.11.2014
2187879	PA2017014	Lithuania		PRODUCT NAME: EMPAGLIFLOZINO IR LINAGLIPTINO DERINYS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA; REGISTRATION NO/DATE: EU/1/16/1146/001 - EU/1/16/1146/018 20161111
1730131	CA 2014 00054	Denmark		PRODUCT NAME: EMPAGLIFLOZIN OG SALTE DERAF, SAERLIGT EMPAGLIFLOZIN; REG. NO/DATE: EU1/14/930/001/018 20140522